Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05202587 · ClinicalTrials.gov registry record
The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 386
- Enrollment target
NCT05202587 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 386 participants.
The verdict
NCT05202587 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 386 participants
- Enrollment target
Study Summary
This multi-center study will enroll Adult subjects diagnosed with neo-vascular age-related macular degeneration (NV-AMD) in at least one eye at the time of enrollment. the subject study duration for this study is one day (2-3 hours). Each study site will have two NVHO devices and one Cirrus 5000 and the patients will be scand on the two NVHO devices and one Cirrus device as a part of the study flow. At the Study Visit, fluid must be present in approximately 280 study eyes and fluid must be absent from 20 study eyes. Each subject will only have one study eye. The fluid status will be determined by the investigator while reviewing an acceptable screening Cirrus OCT volume scan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2023-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05202587
The ClinicalTrials.gov registry entry for NCT05202587 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 386 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Notal Vision, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05202587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05202587 about?
NCT05202587 is a clinical study titled "The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT". This multi-center study will enroll Adult subjects diagnosed with neo-vascular age-related macular degeneration (NV-AMD) in at least one eye at the time of enrollment. the subject study duration for this study is one day (2-3 hours). Each study site will have two NVHO devices and one Cirrus 5000 and...
What is the current status of trial NCT05202587?
This trial is currently completed. The enrollment target is 386 participants. The study started on 2021-11-10. Estimated completion is 2023-01-12.
Who is sponsoring clinical trial NCT05202587?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.